Company Pharmalife Med Srl with Fiscal Code 17096329
recorded a turnover of 2024 of
17.254.842,
with a net profit of
-1.665.292
and having an average number of employees of
80.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Pharmalife Med Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
4.172.704
4.785.892
5.906.798
7.192.752
7.758.234
8.750.254
9.915.395
11.258.307
11.915.470
17.254.842
Total Income - EUR
4.193.205
4.795.545
5.910.580
7.199.698
7.764.644
8.750.319
9.915.469
11.287.145
12.325.014
17.284.478
Total Expenses - EUR
4.061.746
4.628.524
5.744.429
6.749.874
7.229.097
8.241.950
10.054.646
11.616.017
12.491.972
18.949.770
Gross Profit/Loss - EUR
131.460
167.022
166.151
449.824
535.547
508.369
-139.177
-328.871
-166.958
-1.665.292
Net Profit/Loss - EUR
105.017
134.580
134.035
378.501
443.283
441.869
-144.041
-328.871
-166.958
-1.665.292
Employees
36
34
44
42
52
50
54
50
49
80
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 45.6%, from 11.915.470 euro in the year 2023, to 17.254.842 euro in 2024.
Check the financial reports for the company - Pharmalife Med Srl
Financial Rating - PharmaLife MED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Pharmalife Med Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Pharmalife Med Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Pharmalife Med Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Pharmalife Med Srl - CUI 17096329
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
115.501
297.219
221.954
121.285
620.616
942.019
4.167.987
4.192.578
3.877.447
5.323.345
Current Assets
1.906.336
1.898.307
2.684.957
3.454.671
4.763.076
5.866.028
6.692.022
7.596.682
8.013.968
10.428.915
Inventories
754.392
912.168
1.412.162
1.618.699
2.705.675
3.295.130
3.505.415
4.106.547
2.945.255
4.467.898
Receivables
1.054.392
850.884
1.176.062
1.786.432
1.687.958
2.533.113
2.974.976
3.423.834
4.844.110
5.650.518
Cash
97.552
135.256
96.733
49.540
369.443
37.786
211.631
66.301
224.604
310.499
Shareholders Funds
467.470
597.283
721.211
1.086.477
1.508.719
1.899.859
1.708.543
1.384.972
1.213.816
1.842.298
Social Capital
225
223
219
215
211
207
202
203
204
203
Debts
1.560.385
1.611.907
2.197.346
2.502.175
3.889.818
4.927.616
9.138.636
10.422.119
10.704.811
13.892.954
Income in Advance
0
0
0
0
0
0
0
0
0
65
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
10.428.915 euro in 2024 which includes Inventories of
4.467.898 euro, Receivables of
5.650.518 euro and cash availability of
310.499 euro.
The company's Equity was valued at
1.842.298 euro, while total Liabilities amounted to
13.892.954 euro.
Equity increased by 635.266 euro, from 1.213.816 euro in 2023, to 1.842.298 in 2024.
The Debt Ratio was 88.3% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Pharmalife Med Srl